Researchers at the Massachusetts General Hospital in Boston have signed a five-year, $30 million with Johnson and Johnson to bring to market a test that can detect small amounts of cancer cells in blood, reports The Boston Globe's Carolyn Johnson. The researchers have already developed a prototype of the microchip, and the partnership is aimed at refining the test and commercializing it, Johnson adds.
Small Bits of Cancer
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.